Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Gilead Sciences Inc raises FY 2014 net product sales guidance

Wednesday, 23 Jul 2014 04:05pm EDT 

Gilead Sciences Inc:Updates FY 2014 guidance, which it initially provided on Feb. 4, and reiterated on April 22.Raises FY 2014 net product sales in the range of $21.00 - $23.00 bln (previous range $11.30 - $11.50 bln).FY 2014 revenue of $22.63 bln - Thomson Reuters I/B/E/S.